The development and pharmacology of proteasome inhibitors for the management and treatment of cancer.

Advances in pharmacology (San Diego, Calif.)

Volumn 57, Issue , 2009, Pages 91-135

  Ruggeri, Bruce ^a   Miknyoczki, Sheila ^b   Dorsey, Bruce ^b   Hui, Ai Min ^b  

^a CEPHALON INC   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ENZYME INHIBITOR; PROTEASOME;

ANIMAL; CHEMISTRY; CLINICAL TRIAL; DRUG ANTAGONISM; DRUG DEVELOPMENT; DRUG SCREENING; HUMAN; METABOLISM; NEOPLASM; REVIEW;

ANIMALS; CLINICAL TRIALS AS TOPIC; DRUG DISCOVERY; DRUG SCREENING ASSAYS, ANTITUMOR; ENZYME INHIBITORS; HUMANS; NEOPLASMS; PROTEASOME ENDOPEPTIDASE COMPLEX;

MLCS; MLOWN;

EID: 77953154024     PISSN: None     EISSN: 15578925     Source Type: Journal    
DOI: 10.1016/s1054-3589(08)57003-7     Document Type: Review

References (200)